The structure of the nucleoside triphosphate diphosphohydrolases (NTPDases) as revealed by mutagenic and computational modeling analyses.
Over the last seven years our laboratory has focused on the determination of the structural aspects of nucleoside triphosphate diphosphohydrolases (NTPDases) using site-directed mutagenesis and computational comparative protein modeling to generate hypotheses and models for the hydrolytic site and enzymatic mechanism of the family of NTPDase nucleotidases. This review summarizes these studies utilizing NTPDase3 (also known as CD39L3 and HB6), an NTPDase family member that is intermediate in its characteristics between the more widely distributed and studied NTPDase1 (also known as CD39) and NTPDase2 (also known as CD39L1 and ecto-ATPase) enzymes. Relevant site-directed mutagenesis studies of other NTPDases are also discussed and compared to NTPDase3 results. It is anticipated that many of the results and conclusions reached via studies of NTPDase3 will be relevant to understanding the structure and enzymatic mechanism of all the cell-surface members of this family (NTPDase1-3, 8), and that understanding these NTPDase enzymes will aid in modulating the many varied processes under purinergic signaling control. This review also integrates the site-directed mutagenesis results with a recent 3-D structural model for the extracellular portion of NTPDases that helps explain the importance of the apyrase conserved regions (ACRs) of the NTPDases. Utilizing this model and published work from Dr Guidotti's laboratory concerning the importance and characteristics of the two transmembrane helices and their movements in response to substrate, we present a speculative cartoon model of the enzymatic mechanism of the membrane-bound NTPDases that integrates movements of the extracellular region required for catalysis with movements of the N- and C-terminal transmembrane helices that are important for control and modulation of enzyme activity.
Kirley
Terence L
TL
Department of Pharmacology and Cell Biophysics, University of Cincinnati, College of Medicine, 231 Albert Sabin Way, Cincinnati, Ohio, USA.
Crawford
Patrick A
PA
Smith
Thomas M
TM
Biochemistry. 1999 May 4;38(18):5849-57
10231536
Biochemistry. 2000 Jan 11;39(1):9-16
10625474
Biochim Biophys Acta. 2000 Jun 1;1466(1-2):267-77
10825448
Biochemistry. 2000 Jun 13;39(23):6936-43
10841775
Biochemistry. 2001 Apr 3;40(13):3943-50
11300774
Biochim Biophys Acta. 2001 May 5;1547(1):72-81
11343793
J Mol Biol. 2001 Jun 29;310(1):243-57
11419950
Proteins. 2001 Nov 15;45(3):241-61
11599028
Arch Biochem Biophys. 2001 Nov 1;395(1):94-102
11673870
Biochim Biophys Acta. 2001 Oct 18;1549(2):137-47
11690650
J Biol Chem. 2002 Feb 22;277(8):6162-9
11748229
Biochemistry. 2002 Feb 12;41(6):1947-56
11827541
Arch Biochem Biophys. 2002 Oct 1;406(1):85-95
12234494
Arch Biochem Biophys. 2003 May 1;413(1):107-15
12706347
J Biol Chem. 2003 Oct 10;278(41):39960-8
12888562
Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7290-4
1323828
Biochemistry. 2003 Oct 14;42(40):11726-35
14529283
Biochemistry. 2004 Jul 20;43(28):8894-900
15248747
Biochemistry. 2004 Nov 2;43(43):13849-58
15504047
Mol Biol Cell. 2005 Apr;16(4):1661-72
15673609
Biochim Biophys Acta. 2005 May 25;1723(1-3):143-50
15777625
Biochemistry. 2005 Jun 28;44(25):8998-9012
15966724
J Biol Chem. 1991 Dec 5;266(34):23490-8
1660476
Purinergic Signal. 2004 Dec;1(1):51-8
18404400
Purinergic Signal. 2005 Sep;1(3):271-80
18404511
Cell. 1989 Mar 10;56(5):777-83
2493990
J Biol Chem. 1988 Sep 5;263(25):12682-9
2970463
Biochemistry. 1996 Oct 8;35(40):13157-64
8855953
Methods Enzymol. 1997;277:396-404
9379925
J Biol Chem. 1998 Jan 9;273(2):700-4
9422720
J Biol Chem. 1998 Sep 18;273(38):24814-21
9733785
Biochemistry. 1999 Jan 5;38(1):321-8
9890913